Snapshot
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Urokinase by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Urokinase Powder
Urokinase Solution
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Wanhua Biochem
NDPharm
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Urokinase Industry
Figure Urokinase Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Urokinase
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Urokinase
1.2.2 Downstream
Table Application Segment of Urokinase
Table Global Urokinase Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Urokinase Market by Type
3.1 By Type
3.1.1 Urokinase Powder
Table Major Company List of Urokinase Powder
3.1.2 Urokinase Solution
Table Major Company List of Urokinase Solution
3.2 Market Size
Table Global Urokinase Market 2016-2020, by Type, in USD Million
Figure Global Urokinase Market Growth 2016-2020, by Type, in USD Million
Table Global Urokinase Market 2016-2020, by Type, in Volume
Figure Global Urokinase Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Urokinase Market Forecast 2021-2026, by Type, in USD Million
Table Global Urokinase Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Wanhua Biochem (Company Profile, Sales Data etc.)
4.1.1 Wanhua Biochem Profile
Table Wanhua Biochem Overview List
4.1.2 Wanhua Biochem Products & Services
4.1.3 Wanhua Biochem Business Operation Conditions
Table Business Operation of Wanhua Biochem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 NDPharm (Company Profile, Sales Data etc.)
4.2.1 NDPharm Profile
Table NDPharm Overview List
4.2.2 NDPharm Products & Services
4.2.3 NDPharm Business Operation Conditions
Table Business Operation of NDPharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Jiangxi Haoran Bio-Pharma (Company Profile, Sales Data etc.)
4.3.1 Jiangxi Haoran Bio-Pharma Profile
Table Jiangxi Haoran Bio-Pharma Overview List
4.3.2 Jiangxi Haoran Bio-Pharma Products & Services
4.3.3 Jiangxi Haoran Bio-Pharma Business Operation Conditions
Table Business Operation of Jiangxi Haoran Bio-Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Jiangsu Aidea Pharmaceutical (Company Profile, Sales Data etc.)
4.4.1 Jiangsu Aidea Pharmaceutical Profile
Table Jiangsu Aidea Pharmaceutical Overview List
4.4.2 Jiangsu Aidea Pharmaceutical Products & Services
4.4.3 Jiangsu Aidea Pharmaceutical Business Operation Conditions
Table Business Operation of Jiangsu Aidea Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Urokinase Sales Revenue 2016-2020, by Company, in USD Million
Table Global Urokinase Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Urokinase Sales Revenue Share in 2020, by Company, in USD Million
Table Global Urokinase Sales Volume 2016-2020, by Company, in Volume
Table Global Urokinase Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Urokinase Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Urokinase Market Concentration, in 2020
Figure Europe Urokinase Market Market Concentration, in 2020
Figure Asia-Pacific Urokinase MMarket Concentration, in 2020
Figure South America Urokinase Market Concentration, in 2020
Figure Middle East & Africa Urokinase Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Urokinase Demand in Hospital, 2016-2020, in USD Million
Figure Urokinase Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure Urokinase Demand in Clinic, 2016-2020, in USD Million
Figure Urokinase Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Urokinase Demand in Others, 2016-2020, in USD Million
Figure Urokinase Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Urokinase Demand Forecast 2021-2026, by Application, in USD Million
Figure Urokinase Market Growth 2021-2026, by Application, in USD Million
Figure Urokinase Market Share in 2026, by Application, in USD Million
Table Urokinase Demand Forecast 2021-2026, by Application, in Volume
Table Urokinase Market Growth 2021-2026, by Application, in Volume
Table Urokinase Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Urokinase Production 2016-2020, by Region, in USD Million
Table Urokinase Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Urokinase Market 2016-2020, by Region, in USD Million
Table Global Urokinase Market Share 2016-2020, by Region, in USD Million
Table Global Urokinase Market 2016-2020, by Region, in Volume
Table Global Urokinase Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Urokinase Market Size and Growth 2016-2020, in USD Million
Figure North America Urokinase Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Urokinase Market Size 2016-2020, by Country, in USD Million
Table North America Urokinase Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Urokinase Market Size and Growth 2016-2020, in USD Million
Figure Europe Urokinase Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Urokinase Market Size 2016-2020, by Country, in USD Million
Table Europe Urokinase Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Urokinase Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Urokinase Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Urokinase Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Urokinase Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Urokinase Market Size and Growth 2016-2020, in USD Million
Figure South America Urokinase Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Urokinase Market Size 2016-2020, by Country, in USD Million
Table South America Urokinase Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Urokinase Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Urokinase Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Urokinase Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Urokinase Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Urokinase Market Forecast 2021-2026, by Region, in USD Million
Table Urokinase Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Urokinase
2. Table Application Segment of Urokinase
3. Table Global Urokinase Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Urokinase Solution
5. Table Global Urokinase Market 2016-2020, by Type, in USD Million
6. Table Global Urokinase Market 2016-2020, by Type, in Volume
7. Table Global Urokinase Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Urokinase Market Forecast 2021-2026, by Type, in Volume
9. Table Wanhua Biochem Overview List
10. Table Business Operation of Wanhua Biochem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table NDPharm Overview List
12. Table Business Operation of NDPharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Jiangxi Haoran Bio-Pharma Overview List
14. Table Business Operation of Jiangxi Haoran Bio-Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Jiangsu Aidea Pharmaceutical Overview List
16. Table Business Operation of Jiangsu Aidea Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Global Urokinase Sales Revenue 2016-2020, by Company, in USD Million
18. Table Global Urokinase Sales Revenue Share 2016-2020, by Company, in USD Million
19. Table Global Urokinase Sales Volume 2016-2020, by Company, in Volume
20. Table Global Urokinase Sales Volume Share 2016-2020, by Company, in Volume
21. Table Regional Demand Comparison List
22. Table Major Application in Different Regions
23. Table Urokinase Demand Forecast 2021-2026, by Application, in USD Million
24. Table Urokinase Demand Forecast 2021-2026, by Application, in Volume
25. Table Urokinase Market Growth 2021-2026, by Application, in Volume
26. Table Urokinase Market Share in 2026, by Application, in Volume
27. Table Urokinase Production 2016-2020, by Region, in USD Million
28. Table Urokinase Production 2016-2020, by Region, in Volume
29. Table Global Urokinase Market 2016-2020, by Region, in USD Million
30. Table Global Urokinase Market Share 2016-2020, by Region, in USD Million
31. Table Global Urokinase Market 2016-2020, by Region, in Volume
32. Table Global Urokinase Market Share 2016-2020, by Region, in Volume
33. Table North America Urokinase Market Size 2016-2020, by Country, in USD Million
34. Table North America Urokinase Market Size 2016-2020, by Country, in Volume
35. Table Europe Urokinase Market Size 2016-2020, by Country, in USD Million
36. Table Europe Urokinase Market Size 2016-2020, by Country, in Volume
37. Table Asia-Pacific Urokinase Market Size 2016-2020, by Country, in USD Million
38. Table Asia-Pacific Urokinase Market Size 2016-2020, by Country, in Volume
39. Table South America Urokinase Market Size 2016-2020, by Country, in USD Million
40. Table South America Urokinase Market Size 2016-2020, by Country, in Volume
41. Table Middle East & Africa Urokinase Market Size 2016-2020, by Country, in USD Million
42. Table Middle East & Africa Urokinase Market Size 2016-2020, by Country, in Volume
43. Table Urokinase Market Forecast 2021-2026, by Region, in USD Million
44. Table Urokinase Market Forecast 2021-2026, by Region, in Volume
45. Table Price Factors List
List of Figure
1. Figure Urokinase Industry Chain Structure
2. Figure Global Urokinase Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Urokinase Market Growth 2016-2020, by Type, in Volume
4. Figure Global Urokinase Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Urokinase Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Urokinase Market Concentration, in 2020
7. Figure Europe Urokinase Market Market Concentration, in 2020
8. Figure Asia-Pacific Urokinase MMarket Concentration, in 2020
9. Figure South America Urokinase Market Concentration, in 2020
10. Figure Middle East & Africa Urokinase Market Concentration, in 2020
11. Figure Urokinase Demand in Hospital, 2016-2020, in USD Million
12. Figure Urokinase Demand in Hospital, 2016-2020, in Volume
13. Figure Urokinase Demand in Clinic, 2016-2020, in USD Million
14. Figure Urokinase Demand in Clinic, 2016-2020, in Volume
15. Figure Urokinase Demand in Others, 2016-2020, in USD Million
16. Figure Urokinase Demand in Others, 2016-2020, in Volume
17. Figure Urokinase Market Growth 2021-2026, by Application, in USD Million
18. Figure Urokinase Market Share in 2026, by Application, in USD Million
19. Figure North America Urokinase Market Size and Growth 2016-2020, in USD Million
20. Figure North America Urokinase Market Size and Growth 2016-2020, in Volume
21. Figure Europe Urokinase Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Urokinase Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Urokinase Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Urokinase Market Size and Growth 2016-2020, in Volume
25. Figure South America Urokinase Market Size and Growth 2016-2020, in USD Million
26. Figure South America Urokinase Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Urokinase Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Urokinase Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
The global Urokinase Injection market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Urokinase market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eval...
The global Urokinase for Injection market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...
The global Urokinase Lyophilized Powder market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...
The global Urokinase (CAS 9039-53-6) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...
The global Urokinase (CAS 9039-53-6) Industry 2021 market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mar...
The global Urokinase market was valued at 38.26 Million USD in 2020 and will grow with a CAGR of 6.23% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
Summary
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it ...
Summary
HeyReport estimates that the Urokinase for Injection market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this re...
The research team projects that the Urokinase market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user underst...